To address the clinical relevance of GCN2 activation in the pathogenesis of PAH, we first quantified GCN2 mRNA expression in lung tissues from healthy donors and patients with IPAH (Supplemental Table 1) by quantitative RT-PCR analysis. Here, EIF2AK4 is linked to pulmonary arterial hypertension.